Literature DB >> 34596667

Letter regarding Louis et al: The 2021 WHO Classification of Tumors of the Central Nervous System: A summary.

Jigishaa Moudgil-Joshi1, Chandrasekaran Kaliaperumal2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34596667      PMCID: PMC8643450          DOI: 10.1093/neuonc/noab190

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  5 in total

1.  Management of children with brain tumors in Paraguay.

Authors:  Jacquelyn L Baskin; Eva Lezcano; Bo Sung Kim; Diego Figueredo; Alvaro Lassaletta; Antonio Perez-Martinez; Luis Madero; Miguela A Caniza; Scott C Howard; Angelica Samudio; Jonathan L Finlay
Journal:  Neuro Oncol       Date:  2012-11-29       Impact factor: 12.300

2.  ISNO consensus guidelines for practical adaptation of the WHO 2016 classification of adult diffuse gliomas.

Authors:  Vani Santosh; Palavalasa Sravya; Tejpal Gupta; Dattatraya Muzumdar; Geeta Chacko; Vaishali Suri; Sridhar Epari; Anandh Balasubramaniam; Bishan Dass Radotra; Sandip Chatterjee; Chitra Sarkar; Rakesh Jalali
Journal:  Neurol India       Date:  2019 Jan-Feb       Impact factor: 2.117

3.  Cost-Effectiveness of Temozolamide for Treatment of Glioblastoma Multiforme in India.

Authors:  Nidhi Gupta; Shankar Prinja; Vijay Patil; Pankaj Bahuguna
Journal:  JCO Glob Oncol       Date:  2021-01

4.  A Questionnaire-based Survey of Clinical Neuro-oncological Practice in India.

Authors:  Venkatesh S Madhugiri; Aliasgar Moiyadi; Amrutha Bindu Nagella; Vikram Singh; Prakash Shetty
Journal:  Neurol India       Date:  2021 May-Jun       Impact factor: 2.117

Review 5.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Pieter Wesseling; Daniel J Brat; Ian A Cree; Dominique Figarella-Branger; Cynthia Hawkins; H K Ng; Stefan M Pfister; Guido Reifenberger; Riccardo Soffietti; Andreas von Deimling; David W Ellison
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.